A twenty year perspective on melanoma therapy

Melanoma had long been considered to be particularly addressable with immunotherapy, but that reputation was built on modestly effective cytokine‐based immunotherapy. CTLA‐4 antibody therapy reinforced this legacy, but PD‐1 antibodies transformed the melanoma treatment landscape and lead the way for...

Celý popis

Podrobná bibliografia

Vydané v:	Pigment cell and melanoma research Ročník 36; číslo 6; s. 563 - 575
Hlavný autor:	Flaherty, Keith T.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Wiley Subscription Services, Inc 01.11.2023
Predmet:	Antibodies Cancer Combined Modality Therapy Cytokines Humans Immunotherapy Melanoma Melanoma - drug therapy Melanoma - genetics Proto-Oncogene Proteins B-raf - genetics Therapy
ISSN:	1755-1471, 1755-148X, 1755-148X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!